A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman AL, Tainsky MA. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene. 2008; 27:5975-87. [PubMed: 18711403] source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher LA, et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010; 2:458-71. [PubMed: 20941790] sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl L, et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/ adenomas indicates a senescence barrier in the serrated route to colon cancer. Modern Pathology. 2011; 24:1015-22. [PubMed: 21423154] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke M, et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell. 2010; 18:135-46. [PubMed: 20708155] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling J, et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012; 21:105-20. [PubMed: 22264792] sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso M, et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv. 2009; 454:291-302. [PubMed: 19172291] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 801–900 of 2,275
Klepacki, H., Kowalczuk, K., Łepkowska, N., & Hermanowicz, J. M. (2025) · Cells · doi:10.3390/cells14130942 · Cited by 57
“As a result, numerous pro-inflammatory factors are produced and secreted, stimulating growth and modifying the extracellular matrix, which may significantly support tumor formation [86].”
Noncoding RNAs Controlling Telomere Homeostasis in Senescence and Aging
Rossi, M. S., & Gorospe, M. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.010 · Cited by 51
de Montgolfier, O., Thorin‐Trescases, N., & Thorin, É. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa001 · Cited by 50
CXCL5‐CXCR2 signaling is a senescence‐associated secretory phenotype in preimplantation embryos
Kawagoe, Y., Kawashima, I., Sato, Y., Okamoto, N., Matsubara, K., & Kawamura, K. (2020) · Aging Cell · doi:10.1111/acel.13240 · Cited by 39
“Moreover, increasing senescence-associated beta galactosidase (SAβ-GAL) activity was found in normal cells cultured with senescent cells (Acosta et al., 2013).”
BackgroundDeng, L., He, K., Pan, Y., Wang, H., Luo, Y., & Xia, Q. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.56003 · Cited by 40
“These cytokines can affect adjacent tissues and immune cells [15].”
BackgroundSenescent cells in human adipose tissue: A cross‐sectional study
Espinosa De Ycaza, A. E., Søndergaard, E., Morgan‐Bathke, M., Carranza Leon, B. G., Lytle, K. A., Ramos, P., Kirkland, J. L., Tchkonia, T., & Jensen, M. D. (2021) · Obesity · doi:10.1002/oby.23202 · Cited by 39
“Studies have shown that SASP promotes senescence of other cells (30,31), recruitment of immune inflammatory cells (19), and, in the AT of obese mice, can lead to insulin resistance (10,19).”
BackgroundA guide to senolytic intervention in neurodegenerative disease
Lee, S., Wang, E. Y., Steinberg, A. B., Walton, C. C., Chinta, S. J., & Andersen, J. K. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111585 · Cited by 39
Sun, J., Liu, X., Shen, C., Zhang, W., & Niu, Y. (2021) · Cell Proliferation · doi:10.1111/cpr.13155 · Cited by 40
Metabolic Alterations in Cellular Senescence: The Role of Citrate in Ageing and Age-Related Disease
Mycielska, M. E., James, E. N., & Parkinson, E. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073652 · Cited by 40
“Furthermore, many studies on senescent cells employ at the most two cell lines [51,78] and frequently only one [79,80].”
BackgroundAge-Related Midbrain Inflammation and Senescence in Parkinson’s Disease
Russo, T., & Rießland, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.917797 · Cited by 40
“In addition, the SASP has been shown to induce a paracrine spreading of senescence in normal cells both in culture and in mouse models of oncogene induced senescence (OIS) in vivo (Acosta et al., 2013).”
BackgroundInfluentialMarthandan, S., Menzel, U., Priebe, S., Groth, M., Guthke, R., Platzer, M., Hemmerich, P., Kaether, C., & Diekmann, S. (2016) · Biological Research · doi:10.1186/s40659-016-0095-2 · Cited by 39
“Several genes having a role in senescence induction (such as TGFB2, IGF1, Id1, Id3, Id4, IL1B, IL6 and IL8) were among those genes (highlighted in blue in Additional file 10) which were similarly differentially regulated in both replicative and irradiation induced senescence [50, 55, 84, 90–92, 136–143].”
BackgroundDistinct senotypes in p16- and p21-positive cells across human and mouse aging tissues
Saul, D., Jurk, D., Doolittle, M. L., Kosinsky, R. L., Han, Y., Zhang, X., Franco, A. C., Kim, S. Y., Wyles, S. P., Prakash, Y. S., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00601-2 · Cited by 45
“These effects include the propagation of senescence (Acosta et al, 2013), modulation of tissue repair processes (Demaria et al, 2014; Moiseeva et al, 2023; Saul et al, 2021), and recruitment of immune cells (Lagnado et al, 2021).”
Senescent cells at the crossroads of aging, disease, and tissue homeostasis
Kuehnemann, C., & Wiley, C. D. (2023) · Aging Cell · doi:10.1111/acel.13988 · Cited by 51
“…inflammation, the SASP has additional properties including promoting hemostasis, fibrosis, tumor growth and invasion, and even paracrine induction of senescence in other cells (Acosta et al., 2013; Coppe et al., 2008; Schafer et al., 2017; Wiley, Brumwell, et al., 2019; Wiley, Liu, et al., 2019).”
BackgroundTu, J., Jiang, F., Fang, J., Xu, L., Zeng, Z., Zhang, X., Ba, L., Liu, H., & Lin, F. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s438398 · Cited by 43
“48 PANoptosis, a precise form of programmed inflammatory cell death, 49,50 regulates immune cells, influencing immune cell infiltration and facilitating inflammation resolution.”
BackgroundTakaya, K., & Kishi, K. (2024) · Biogerontology · doi:10.1007/s10522-024-10103-z · Cited by 50
“…and organ dysfunction by disrupting the stem cell niche, which, in turn, induces abnormal cell differentiation, destroys the extracellular matrix (ECM), stimulates tissue inflammation, and induces the same process in adjacent cells (Coppé et al. 2010; Snijders et al. 2013; Salama et al. 2014).”
Bhardwaj, S., Gautam, R. K., & Kushwaha, S. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.08.003 · Cited by 55
Parisi, M. M., Grün, L. K., Lavandoski, P., Alves, L. B., Bristot, I. J., Mattiello, R., Mottin, C. C., Klamt, F., Jones, M. H., Padoin, A. V., et al. (2017) · Obesity · doi:10.1002/oby.21888 · Cited by 42
“Premature accumulation of senescent cells enhances the oxidative and inflammatory signaling that induces DNA damage and mitochondrial dysfunction in a paracrine manner in surrounding cells in different tissues, creating a vicious cycle (8).”
BackgroundSimoncini, S., Château, A.-L., Robert, S., Todorova, D., Yzydorzick, C., Lacroix, R., Ligi, I., Louis, L., Bachelier, R., Siméoni, U., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08883-1 · Cited by 43
“…such as cytokines, proteases, and extracellular vesicles (EV) 16, 17 modulate the behavior of neighboring cells in a paracrine and/or autocrine manner, alter the cellular microenvironment, and can contribute to the functional decline of tissues and the progression of aging-related diseases 18–20 .”
BackgroundSundar, I. K., Rashid, K., Gerloff, J., Rangel‐Moreno, J., Li, D., & Rahman, I. (2018) · The FASEB Journal · doi:10.1096/fj.201701518r · Cited by 38
“Our data on SASP mediators and cellular senescence biomarkers identified in lungs of CS-exposed mice are comparable with SASP factors and senescence genes measured in senescent cells or in ageassociated pathologies (39, 40).”
BackgroundChikenji, T., Saito, Y., Konari, N., Nakano, M., Mizue, Y., Otani, M., & Fujimiya, M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.05.012 · Cited by 42
“This process, mediated by paracrine transmission of cellular senescence, has been termed “bystander senescence” [47,48].”
BackgroundRole of Senescent Renal Cells in Pathophysiology of Diabetic Kidney Disease
Wiley, C. D. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01314-y · Cited by 39
Induction and transmission of oncogene-induced senescence
Rattanavirotkul, N., Kirschner, K., & Chandra, T. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03638-0 · Cited by 43
Senolytics in the treatment of diabetic retinopathy
Hassan, J. W., & Bhatwadekar, A. D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.896907 · Cited by 39
“RIG-I is a cytosolic pattern recognition receptor (PRR) responsible for sensing cytoplasmic RNA and leading to senescence-associated inflammation (Acosta et al., 2013).”
BackgroundWang, A., Yang, F., Tian, Y., Su, J.-H., Gu, Q., Chen, W., Gong, S.-X., Ma, X., Qin, X.-P., & Jiang, Z. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.656139 · Cited by 49
“(Coppe et al., 2010; Acosta et al., 2013), which promotes the occurrence and development of tumor; paracrine IL-6 can induce the proliferation of human lung fibroblasts and the growth and metastasis of pancreatic cancer cells (Huang et al.”
BackgroundDynamic regulation of myofibroblast phenotype in cellular senescence
López‐Antona, I., Contreras‐Jurado, C., Luque‐Martín, L., Carpintero‐Leyva, A., González‐Méndez, P., & Palmero, I. (2022) · Aging Cell · doi:10.1111/acel.13580 · Cited by 40
Periodontal disease as a model to study chronic inflammation in aging
Bertolini, M., & Clark, D. R. (2023) · GeroScience · doi:10.1007/s11357-023-00835-0 · Cited by 50
“Senescent cells accumulate in tissue with increased age, and some develop the senesce-asso-ciated secretory phenotype (SASP), which describes the secretion of proinflammatory cytokines and chemokines [103, 104].”
Gleason, C. E., Dickson, M. A., Klein, M. E., Antonescu, C. R., Gularte‐Mérida, R., Benitez, M., Delgado, J. I., Kataru, R. P., Tan, M. W. Y., Bradić, M., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2378 · Cited by 43
“11 –”
BackgroundInfluentialImmune surveillance of senescent cells in aging and disease
Majewska, J., & Krizhanovsky, V. (2025) · Nature Aging · doi:10.1038/s43587-025-00910-5 · Cited by 58
“Senescent cell accumulation executes its deleterious effects mainly through the SASP, leading to chronic inflammation, induction of tissue dysfunction, promotion of fibrosis and exhaustion of stem cells 15–19 .”
Cellular senescence in liver diseases: From molecular drivers to therapeutic targeting
Du, K., Umbaugh, D. S., Ren, N., & Diehl, A. M. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.08.021 · Cited by 49
Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease
Hruby, A. J., & Higuchi‐Sanabria, R. (2025) · npj Aging · doi:10.1038/s41514-025-00291-4 · Cited by 63
Chen, L., Wang, G., Wang, Q., Liu, Q., Sun, Q., & Chen, L. (2019) · PubMed · Cited by 45
Feng, M., Peng, H., Yao, R., Zhang, Z., Mao, G., Yu, H., & Qiu, Y. (2020) · Bone · doi:10.1016/j.bone.2020.115522 · Cited by 47
Wilhelmsen, A., Tsintzas, K., & Jones, S. W. (2021) · GeroScience · doi:10.1007/s11357-021-00322-4 · Cited by 44
Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review
Fakhri, S., Moradi, S. Z., Ash-Rafzadeh, A., & Bishayee, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105961 · Cited by 39
Age and metastasis – How age influences metastatic spread in cancer. Colorectal cancer as a model
Pretzsch, E., Nieß, H., Bösch, F., Westphalen, C. B., Jacob, S., Neumann, J. H. L., Werner, J., Heinemann, V., & Angele, M. K. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102112 · Cited by 41
Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies
Fakhri, S., Moradi, S. Z., DeLiberto, L. K., & Bishayee, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114989 · Cited by 42
Barnes, P. J. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_3 · Cited by 40
Advancing biological understanding of cellular senescence with computational multiomics
Li, S., Agudelo Garcia, P. A., Aliferis, C., Becich, M. J., Calyeca, J., Cosgrove, B. D., Elisseeff, J., Farzad, N., Fertig, E. J., Glass, C., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02314-y · Cited by 40
Reamon-Buettner, S. M., Hackbarth, A., Leonhardt, A., Braun, A. C., & Ziemann, C. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111412 · Cited by 38
Role of Oxidative Stress in the Senescence Pattern of Auditory Cells in Age-Related Hearing Loss
Chacón, L. D. M. R., Martínez-Rodríguez, S., Madrid, R., Yanes‐Diaz, J., Riestra‐Ayora, J., Fernández, R. S., & Sánchez‐Rodríguez, C. (2021) · Antioxidants · doi:10.3390/antiox10091497 · Cited by 42
“The SASP and enhanced ROS production contribute to cellular senescence in both autocrine [17,18] and paracrine ways [19,20].”
BackgroundHong, X., Wang, L., Zhang, K., Liu, J., & Liu, J. (2022) · Cells · doi:10.3390/cells11050877 · Cited by 38
Aging and diabetic retinopathy: Inherently intertwined pathophysiological processes
Li, Q., Wang, M., Li, X., & Shao, Y. X. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112138 · Cited by 42
Pro‐inflammatory cytokines mediating senescence of vascular endothelial cells in atherosclerosis
Shang, D., Liu, H., & Tu, Z. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12915 · Cited by 39
“Studies have shown that certain pro-inflammatory cytokines can induce cellular senescence and are associated with age-related chronic diseases [41, 71].”
BackgroundRovere, M., Reverberi, D., Arnaldi, P., Palamà, M. E. F., & Gentili, C. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1297644 · Cited by 46
Vétillard, A., Jonchère, B., Moreau, M., Toutain, B., Henry, C., Fontanel, S., Bernard, A.-C., Campone, M., Guette, C., & Coqueret, O. (2015) · Oncotarget · doi:10.18632/oncotarget.6126 · Cited by 36
“The activity of the SASP is complex; depending on the experimental conditions, it has either a suppressive [10, 11] or an oncogenic function [12-14].”
An Arf-Egr-C/EBPβ Pathway Linked to Ras-Induced Senescence and Cancer
Salotti, J., Sakchaisri, K., Tourtellotte, W. G., & Johnson, P. F. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01489-14 · Cited by 40
“In addition to exhibiting growth arrest and positive staining for SA- Gal, senescent cells express and secrete senescence-associated secretory phenotype (SASP) factors, some of which are direct targets of C/EBP (4, 5, 11, 23).”
BackgroundBiomarkers in the path from cellular senescence to frailty
Zampino, M., Ferrucci, L., & Semba, R. D. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110750 · Cited by 42
Zhao, Y., Wu, Z., Chanal, M., Guillaumond, F., Goehrig, D., Bachy, S., Principe, M., Ziverec, A., Flaman, J., Collin, G., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3763 · Cited by 40
mTOR as a senescence manipulation target: A forked road
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2021.02.002 · Cited by 35
Nutrition and cellular senescence in obesity-related disorders
Rubio‐Tomás, T., Rueda‐Robles, A., Plaza‐Díaz, J., & Álvarez‐Mercado, A. I. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108861 · Cited by 43
A geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials
Gonzales, M. M., Krishnamurthy, S., Garbarino, V. R., Daeihagh, A. S., Gillispie, G. J., Deep, G., Craft, S., & Orr, M. E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111589 · Cited by 38
Plasma Proteomics of COVID-19–Associated Cardiovascular Complications
Roh, J. D., Kitchen, R. R., Guseh, J. S., McNeill, J. N., Aïd, M., Martinot, A. J., Yu, A., Platt, C., Rhee, J., Weber, B., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.01.013 · Cited by 53
Sirtuin-1 attenuates cadmium-induced renal cell senescence through p53 deacetylation
Chou, X., Li, X., Min, Z., Ding, F., Ma, K., Shen, Y. L., Sun, D., & Wu, Q. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114098 · Cited by 37
Procyanidin B2 ameliorates the progression of osteoarthritis: An in vitro and in vivo study
Cai, W., Zhang, Y., Jin, W., Wei, S., Chen, J., Zhong, C., Zhong, Y., Tu, C., & Peng, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109336 · Cited by 43
Lee, J. Y., Yu, K.-R., Lee, B.-C., Kang, I., Kim, J.-J., Jung, E.-J., Kim, H.-S., Seo, Y., Choi, S. W., & Kang, K.-S. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0092-3 · Cited by 36
Zhao, S., Qiao, Z., Pfeifer, R., Pape, H.-C., Mao, K., Tang, H., Meng, B., Chen, S., & Liu, H. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01604-7 · Cited by 35
“IL-1a is an upstream regulator of other SASP and regulates the secretion of other SASP [8, 16, 28].”
BackgroundGrotheer, V., Skrynecki, N., Oezel, L., Windolf, J., & Grassmann, J. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-91501-y · Cited by 41
Role of Peritoneal Mesothelial Cells in the Progression of Peritoneal Metastases
Li, J., & Guo, T. (2022) · Cancers · doi:10.3390/cancers14122856 · Cited by 39
Sun, D., Singh, D. K., Carcamo, S., Filipescu, D., Khalil, B. D., Huang, X., Miles, B. A., Westra, W. H., Sproll, K. C., Hasson, D., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo0876 · Cited by 43
Ferreira-González, S., Man, T. Y., Esser, H., Aird, R. E., Kilpatrick, A. M., Rodrigo‐Torres, D., Younger, N. T., Campana, L., Gadd, V. L., Dwyer, B. J., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj4375 · Cited by 38
“A. Salminen, A. Kauppinen, K. Kaarniranta, Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP).”
BackgroundInfluentialSelf-citationAutophagy inhibition signals through senescence to promote tumor suppression
Peng, N., Kang, H. H., Feng, Y., Minikes, A. M., & Jiang, X. (2022) · Autophagy · doi:10.1080/15548627.2022.2155794 · Cited by 39
“Further, we found that neutralizing antibody against VEGF, a reported promotor of paracrine senescence [30], as well as neutralizing antibody against IL8 or CXCL1, attenuated paracrine senescence 1766 N.”
BackgroundPreininger, M. K., Zaytseva, D., Lin, J. M., & Kaufer, D. (2023) · Aging Cell · doi:10.1111/acel.13747 · Cited by 36
“Also, TGFβ1 as a SASP component was found to be an important mediator of paracrine senescence in vivo (Acosta et al., 2013).”
BackgroundCell Survival, Death, and Proliferation in Senescent and Cancer Cells: the Role of (Poly)phenols
Sorrenti, V., Buriani, A., Fortinguerra, S., Davinelli, S., Scapagnini, G., Cassidy, A., & Vivo, I. D. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.05.014 · Cited by 39
“By acting in a paracrine fashion, SASP factors strengthen the senescence of senescent cells themselves and induce the senescence of surrounding cells (paracrine senescence) [58].”
BackgroundCellular senescence in liver diseases: From mechanisms to therapies
Ge, T., Shao, Y., Bao, X., Xu, W., & Lu, C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110522 · Cited by 38
Contribution of viral and bacterial infections to senescence and immunosenescence
Reyes, A., Ortiz, G., Duarte, L. F., Fernández, C., Hernández‐Armengol, R., Palacios, P. A., Prado, Y., Andrade, C. A., Rodríguez‐Guilarte, L., Kalergis, A. M., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1229098 · Cited by 39
“, 2016), and cytokines (Acosta et al., 2013), among others (Campisi and d’Adda di Fagagna, 2007; Kuilman et al.”
BackgroundTransplanting old organs promotes senescence in young recipients
Iske, J., Roesel, M. J., Martin, F., Schroeter, A., Matsunaga, T., Maenosono, R., Tripathi, U., Xiao, Y., Nian, Y., Caldarone, B. J., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.10.013 · Cited by 37
Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia
Englund, D. A., Jolliffe, A. M., Hanson, G. J., Aversa, Z., Zhang, X., Jiang, X., White, T. A., Zhang, L. J., Monroe, D. G., Robbins, P. D., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.169512 · Cited by 43
Zhan, Y., Huang, Q., Deng, Z., Chen, S., Yang, R., Zhang, J., Zhang, Y., Peng, M., Wu, J., Gu, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.02.005 · Cited by 49
Senescence, NK cells, and cancer: navigating the crossroads of aging and disease
Gergues, M., Bari, R., Koppisetti, S., Gosiewska, A., Kang, L., & HARIRI, R. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1565278 · Cited by 52
Karpuzoglu, E., Holladay, S. D., & Gogal, R. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1704203 · Cited by 66
The nuclear receptor NR2E1/TLX controls senescence
O'Loghlen, A., Martin, N., Krusche, B., Pemberton, H., Alonso, M. M., Chandler, H., Brookes, S., Parrinello, S., Peters, G., & Gil, J. (2015) · Oncogene · doi:10.1038/onc.2014.335 · Cited by 35
“Knockdown of p16 INK4a , and CBX7 was achieved using validated shRNA constructs 2, 28 .”
Self-citationMalavolta, M., Costarelli, L., Giacconi, R., Piacenza, F., Basso, A., Pierpaoli, E., Marchegiani, F., Cardelli, M., Provinciali, M., & Mocchegiani, E. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.02.006 · Cited by 37
“[27] Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, et al.”
BackgroundHypoxia negatively affects senescence in osteoclasts and delays osteoclastogenesis
Gorissen, B. M. C., de Bruin, A., Bedate, A. M., Korthagen, N. M., Wolschrijn, C. F., de Vries, T. J., van Weeren, P. R., & Tryfonidou, M. A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26511 · Cited by 37
“Senescence is not limited to the arrest of proliferation, but also includes the acquirement of the senescence associated secretory phenotype (SASP) (Terzi et al., 2016), characterized by the production and secretion of soluble signaling factors (Coppé et al., 2010).”
BackgroundInfluentialConnecting cancer relapse with senescence
Pluquet, O., Abbadie, C., & Coqueret, O. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.08.004 · Cited by 39
Melatonin antagonizes ovarian aging via YTHDF2-MAPK-NF-κB pathway
Zhu, R., Ji, X., Wu, X., Chen, J., Li, X., Jiang, H., Fu, H., Wang, H., Lin, Z., Tang, X., et al. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.08.005 · Cited by 43
“Inflammation is one of the major contributors to senescence.(9,10) The SASP, which is known for altering the secretory activities of senescent cells, includes proinflammatory cytokines, chemokines, growth factors, and proteases.”
BackgroundSerrano‐López, J., & Martín-Antonio, B. (2021) · Cells · doi:10.3390/cells10102562 · Cited by 43
“Furthermore, the SASP transmits cellular senescence to neighboring non-senescent cells [27,28], leading to enhanced senescence and inflammaging.”
BackgroundTendon Extracellular Matrix Assembly, Maintenance and Dysregulation Throughout Life
Siadat, S. M., Zamboulis, D. E., Thorpe, C. T., Ruberti, J. W., & Connizzo, B. K. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-80614-9_3 · Cited by 49
Endothelial and systemic upregulation of miR-34a-5p fine-tunes senescence in progeria
Manakanatas, C., Ghadge, S. K., Agic, A., Sarigol, F., Fichtinger, P., Fischer, I., Foisner, R., & Osmanagic‐Myers, S. (2022) · Aging · doi:10.18632/aging.203820 · Cited by 38
“Here we could validate the systemic inflammatory effects of endothelial cells in vivo by showing upregulation of top-most immune response candidates, CCl20 and Il1a in the lung and heart tissues and corresponding ECs and also circulating in plasma, in line with dramatic immune cell infiltrates in the vicinity of blood…”
BackgroundInfluentialLehmann, J., Narcisi, R., Franceschini, N., Chatzivasileiou, D., Boer, C. G., Koevoet, W. J. L. M., Putavet, D. A., Drabek, D., van Haperen, R., de Keizer, P. L. J., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04035-x · Cited by 40
“Since proinflammatory cytokines and TGFβ superfamily members are induced in response to tissue injury (reviewed in [115]), this mechanism might be particularly important during regenerative processes.”
BackgroundInfluentialGkaliagkousi, Ε., Lazaridis, A. A., Doğan, S., Fraenkel, E., Tuna, B. G., Mozos, I. M., VUKIĆEVIĆ, M., Yalçın, Ö., & Gopčević, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158672 · Cited by 39
“The senescence-associated secretory phenotype (SASP) consists of a plethora of factors produced by the senescent cells including pro-inflammatory cytokines and chemokines, growth modulators, angiogenic factors, and MMPs that can induce inflammation, stem cell dysfunction, immunity activation, apoptosis and further tri…”
BackgroundCellular senescence and neurodegeneration
Holloway, K., Neherin, K., Dam, K. U., & Zhang, H. (2023) · Human Genetics · doi:10.1007/s00439-023-02565-x · Cited by 43
The Molecular Intersection Between Senescence and Major Depression in the Elderly
Diniz, B. S. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.07.005 · Cited by 39
Ikegami, K., Yamashita, M., Suzuki, M., Nakamura, T., Hashimoto, K., Kitagaki, J., Yanagita, M., Kitamura, M., & Murakami, S. (2023) · Aging · doi:10.18632/aging.204569 · Cited by 48
Single-Cell RNA-Sequencing Reveals the Skeletal Cellular Dynamics in Bone Repair and Osteoporosis
Wu, S., Ohba, S., & Matsushita, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129814 · Cited by 42
“Furthermore, senescent cells from the osteoblast lineage produce a unique senescence-associated secretory phenotype (SASP) signal that leads to the over-secretion of a complex array of cytokines, chemokines, and matrix-degrading proteases, thereby creating a toxic microenvironment that results in age-related bone loss…”
BackgroundRoger, E., Chadjichristos, C. E., Kavvadas, P., Price, G. W., Cliff, C. L., Hadjadj, S., Renciot, J., Squires, P. E., & Hills, C. E. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01245-7 · Cited by 36
“Exhibiting low affinity for ATP, expression of the P2X7R is upregulated in CKD [15] with activation linked to increased NLRP3 activity [61], increased senescence [62, 63] and EMT [64].”
BackgroundAutophagy-mediated control of ribosome homeostasis in oncogene-induced senescence
López, A. R., Jørgensen, M. H., Havelund, J. F., Arendrup, F. S., Kolapalli, S. P., Nielsen, T. M., Pais, E., Beese, C. J., Abdul-Al, A., Vind, A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113381 · Cited by 40
New insights into nucleic acid sensor AIM2: The potential benefit in targeted therapy for cancer
Cui, J.-Z., Chew, Z. H., & Lim, L. H. K. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107079 · Cited by 37
Cheng, P., Yu, F., Chen, S.-J., Feng, X. M., Jia, Z.-H., Hu, S., Cui, X.-L., Zhou, Y., Niu, Q., Liang, L., et al. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123674 · Cited by 38
IL-23R is a senescence-linked circulating and tissue biomarker of aging
Carver, C. M., Rodriguez, S. L., Atkinson, E. J., Dosch, A. J., Asmussen, N. C., Gomez, P. T., Leitschuh, E. A., Espíndola‐Netto, J. M., Jeganathan, K. B., Whaley, M. G., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00752-7 · Cited by 43
Enhancing immunity during ageing by targeting interactions within the tissue environment
Bracken, O. V., Maeyer, R. P. H. D., & Akbar, A. N. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01126-9 · Cited by 46
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 29
Shibamoto, M., Higo, T., Naito, A. T., Nakagawa, A., Sumida, T. S., Okada, K., Sakai, T., Kuramoto, Y., Yamaguchi, T., Ito, M., et al. (2019) · International Heart Journal · doi:10.1536/ihj.18-701 · Cited by 38
Rohn, F., Kordes, C., Buschmann, T., Reichert, D., Wammers, M., Poschmann, G., Stühler, K., Benk, A. S., Geiger, F., Spatz, J. P., et al. (2020) · Aging Cell · doi:10.1111/acel.13131 · Cited by 34
“These factors induce senescence and the release of SASP factors by neighboring cells in a paracrine manner (Acosta et al., 2013).”
BackgroundRuiz, R., Chen, C., Razzak, E., Vasudeva, P., Krasieva, T. B., Shiu, J., Caldwell, M. G., Yan, H., Lowengrub, J. S., Ganesan, A. K., et al. (2020) · eLife · doi:10.7554/elife.61026 · Cited by 39
The combination of mitogenic stimulation and DNA damage induces chondrocyte senescence
Copp, M. E., Flanders, M. C., Gagliardi, R., Gilbertie, J. M., Sessions, G. A., Chubinskaya, S., Loeser, R. F., Schnabel, L. V., & Diekman, B. O. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.11.004 · Cited by 41
“There is also evidence of an interactive effect with TGF-β in cluster formation[48], which is of particular interest given the finding that TGF-β is a key mediator of senescence in certain contexts[49].”
BackgroundThe Connection Between Cell Fate and Telomere
Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_3 · Cited by 41
Role of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers
Netti, G. S., Franzin, R., Stasi, A., Spadaccino, F., Strologo, A. D., Infante, B., Gesualdo, L., Castellano, G., Ranieri, E., & Stallone, G. (2021) · Cells · doi:10.3390/cells10092426 · Cited by 37
“activation of ATM, ATR, CHK1, and CHK2 kinases, DDR response culminates in p53 stabilization, thereby in cell cycle temporary arrest, allowing DNA damage repair or in case of irreversible injury senescence or apoptosis [20,24,25].”
BackgroundFernández-Duran, I., Quintanilla, A., Tarrats, N., Birch, J., Hari, P., Millar, F. R., Lagnado, A. B., Smer-Barreto, V., Muir, M., Brunton, V. G., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00917-6 · Cited by 39
“The SASP can induce senescence in adjacent growing cells through paracrine signaling, which is dependent on IL-1 signaling [5].”
BackgroundInfluentialSelf-citationWang, C., Long, Q., Fu, Q., Xu, Q., Fu, D., Li, Y., Gao, L., Guo, J., Zhang, X., Lam, E. W. ‐., et al. (2021) · Oncogene · doi:10.1038/s41388-022-02476-7 · Cited by 39
Context‐dependent roles of cellular senescence in normal, aged, and disease states
Moiseeva, V., Cisneros, A., Cobos, A. C., Tarrega, A. B., Oñate, C. S., Perdiguero, E., Serrano, A. L., & Muñoz‐Cánoves, P. (2023) · The FEBS Journal · doi:10.1111/febs.16573 · Cited by 34
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.